Cannabinoids as Emergent Therapy Against COVID-19.
Cannabis Cannabinoid Res
; 7(5): 582-590, 2022 10.
Article
in English
| MEDLINE | ID: covidwho-2077548
ABSTRACT
The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory distress syndrome coronavirus 2 (SARS-Cov-2), was identified for the first time in late 2019 in China, resulting in a global pandemic of massive impact. Despite a fast development and implementation of vaccination strategies, and the scouting of several pharmacological treatments, alternative effective treatments are still needed. In this regard, cannabinoids represent a promising approach because they have been proven to exhibit several immunomodulatory, anti-inflammatory, and antiviral properties in COVID-19 disease models and related pathological conditions. This mini-review aims at providing a practical brief overview of the potential applications of cannabinoids so far identified for the treatment and prevention of COVID-19, finally considering key aspects related to their technological and clinical implementation.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Cannabinoids
/
COVID-19 Drug Treatment
Type of study:
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Cannabis Cannabinoid Res
Year:
2022
Document Type:
Article
Affiliation country:
Can.2022.0018
Similar
MEDLINE
...
LILACS
LIS